-+ 0.00%
-+ 0.00%
-+ 0.00%

Avadel Pharmaceuticals Completes Enrollment in Phase 3 Trial of LUMRYZ for Idiopathic Hypersomnia

Reuters·12/18/2025 12:01:32

Please log in to view news